Treatment of infantile cystic acne with oral isotretinoin: a case report.
Infantile cystic acne is rare, and its etiology is not clearly defined. Our patient had comedones at 2 months of age that were recalcitrant to multiple-antibiotic regimens. His condition worsened, and he was diagnosed with infantile cystic acne at 10 months of age and started on a trial of oral isotretinoin (Accutane). A five-month treatment period using doses ranging from 0.36 to 0.67 mg/kg was necessary to achieve adequate control. Oral isotretinoin may be safe and effective in cases of recalcitrant infantile acne, but we advocate close monitoring because of the well-known side effects of oral retinoids.
Arbegast
K D
KD
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-4360.
Braddock
S W
SW
Lamberty
L F
LF
Sawka
A R
AR
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000473:pathology; D002675:Child, Preschool; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use*; D008297:Male
D015474:Isotretinoin